Literature DB >> 16858118

Levofloxacin induced myasthenia crisis.

A Gunduz, S Turedi, A Kalkan, I Nuhoglu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16858118      PMCID： PMC2564188          DOI： 10.1136/emj.2006.038091

Source DB:  PubMed          Journal:  Emerg Med J        ISSN： 1472-0205            Impact factor:   2.740


× No keyword cloud information.
  3 in total

1.  Trovafloxacin-induced weakness due to a demyelinating polyneuropathy.

Authors:  C K Murray; G W Wortmann
Journal:  South Med J       Date:  2000-05       Impact factor: 0.954

2.  Myasthenic crisis: a retrospective study.

Authors:  S Panda; Vinay Goyal; M Behari; S Singh; T Srivastava
Journal:  Neurol India       Date:  2004-12       Impact factor: 2.117

3.  Fluoroquinolone antibiotics block neuromuscular transmission.

Authors:  J P Sieb
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910
  3 in total
  2 in total

Review 1.  Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.

Authors:  S Christopher Jones; Alfred Sorbello; Robert M Boucher
Journal:  Drug Saf       Date:  2011-10-01       Impact factor: 5.606

Review 2.  New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review.

Authors:  Tsubasa Takizawa; Marenori Kojima; Shigeaki Suzuki; Takashi Osada; Satoshi Kitagawa; Jin Nakahara; Shinichi Takahashi; Norihiro Suzuki
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.